PATENT CLAIM ANALYSIS

Application Number: 16173871
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "211090"]

Abstract:
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g., HDAC6, having a Formula I: where R, L, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 , Y 3 , and Y 4  are described herein.

Claim (Index 44):
The composition of  claim 43 , wherein the composition further comprises an ester:

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.47826
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15013816', '15013814', '15013820', '15013826', '16133918']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7975949895250553
- 35 USC 102 Novelty (BERT): 0.5310833288711356
- Combined Prediction Score: 0.7709438234596633
- Mean Citation Score: 323.965308
- Max Citation Score: 330.59634
- Similarity Product: 184.3863996665096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test